These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14679296)

  • 1. Apoptosis a relevant therapeutic target in rheumatoid arthritis?
    Smith MD; Walker JG
    Rheumatology (Oxford); 2004 Apr; 43(4):405-7. PubMed ID: 14679296
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation dependent apoptosis of peripheral blood mononuclear cells from patients with rheumatoid arthritis treated with methotrexate.
    Swierkot J; Miedzybrodzki R; Szymaniec S; Szechinski J
    Ann Rheum Dis; 2004 May; 63(5):599-600. PubMed ID: 15082496
    [No Abstract]   [Full Text] [Related]  

  • 3. Lessons from magnetic resonance imaging studies in rheumatoid arthritis.
    Quinn M
    J Rheumatol; 2008 Mar; 35(3):372-4. PubMed ID: 18322971
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of infliximab treatment on rheumatoid synovial tissue.
    Tak PP
    J Rheumatol Suppl; 2005 Mar; 74():31-4. PubMed ID: 15742462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptotic effect of rituximab on peripheral blood B cells in rheumatoid arthritis.
    Szodoray P; Alex P; Dandapani V; Nakken B; Pesina J; Kim X; Wallis GL; Wilson PC; Jonsson R; Centola M
    Scand J Immunol; 2004; 60(1-2):209-18. PubMed ID: 15238091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of apoptosis in peripheral blood and synovial tissue very early after initiation of infliximab treatment in rheumatoid arthritis patients.
    Wijbrandts CA; Remans PH; Klarenbeek PL; Wouters D; van den Bergh Weerman MA; Smeets TJ; Vervoordeldonk MJ; Baeten D; Tak PP
    Arthritis Rheum; 2008 Nov; 58(11):3330-9. PubMed ID: 18975323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis.
    Cutolo M; Sulli A; Pizzorni C; Seriolo B; Straub RH
    Ann Rheum Dis; 2001 Aug; 60(8):729-35. PubMed ID: 11454634
    [No Abstract]   [Full Text] [Related]  

  • 8. Rheumatoid arthritis: is the disease becoming milder or is treatment improving?
    Walji S; Bykerk VP
    J Rheumatol; 2004 Jun; 31(6):1023-5. PubMed ID: 15170908
    [No Abstract]   [Full Text] [Related]  

  • 9. Is the outcome of rheumatoid arthritis changed with the use of new disease-modifying antirheumatic drugs?
    Kremer J
    Arthritis Rheum; 2005 Oct; 53(5):636-8. PubMed ID: 16208649
    [No Abstract]   [Full Text] [Related]  

  • 10. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Clin Geriatr Med; 2005 Aug; 21(3):649-69, viii. PubMed ID: 15911212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of rheumatoid arthritis with etanercept.
    Genovese MC; Kremer JM
    Rheum Dis Clin North Am; 2004 May; 30(2):311-28, vi-vii. PubMed ID: 15172043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac complications may be higher with use of proteasome inhibitors in patients with rheumatoid arthritis.
    Khan S
    Med Hypotheses; 2008 Nov; 71(5):818. PubMed ID: 18650027
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone mineral density in patients with rheumatoid arthritis treated with infliximab.
    Vis M; Voskuyl AE; Wolbink GJ; Dijkmans BA; Lems WF;
    Ann Rheum Dis; 2005 Feb; 64(2):336-7. PubMed ID: 15647447
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological agents in rheumatoid arthritis.
    Shankar S; Handa R
    J Postgrad Med; 2004; 50(4):293-9. PubMed ID: 15623977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cyclophosphamide in the therapy of rheumatoid arthritis and its complications].
    Trefler J; Matyska-Piekarska E; Łacki JK
    Pol Merkur Lekarski; 2007 Jun; 22(132):566-70. PubMed ID: 17874631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How antirheumatic drugs protect joints from damage in rheumatoid arthritis.
    Schett G; Stach C; Zwerina J; Voll R; Manger B
    Arthritis Rheum; 2008 Oct; 58(10):2936-48. PubMed ID: 18821703
    [No Abstract]   [Full Text] [Related]  

  • 17. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Rheum Dis Clin North Am; 2007 Feb; 33(1):197-217. PubMed ID: 17367700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are all DMARDs equivalent?
    Lipsky PE
    Nat Clin Pract Rheumatol; 2008 May; 4(5):223. PubMed ID: 18438424
    [No Abstract]   [Full Text] [Related]  

  • 19. Disease-modifying antirheumatic drugs.
    Brasington R
    J Hand Surg Am; 2009 Feb; 34(2):347-8. PubMed ID: 19181237
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacogenomics of methrotexate: a strategy for a customized therapeutic scheme for patients with rheumatoid arthritis].
    Mena-Ramírez JP; Salazar-Páramo M; Dávalos-Rodríguez IP
    Gac Med Mex; 2008; 144(5):449-51. PubMed ID: 19043967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.